Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

207 related articles for article (PubMed ID: 34575979)

  • 1. The miR-133a, TPM4 and TAp63γ Role in Myocyte Differentiation Microfilament Remodelling and Colon Cancer Progression.
    Caporali S; Calabrese C; Minieri M; Pieri M; Tarantino U; Marini M; D'Ottavio S; Angeletti S; Mauriello A; Cortese C; Bernardini S; Terrinoni A
    Int J Mol Sci; 2021 Sep; 22(18):. PubMed ID: 34575979
    [TBL] [Abstract][Full Text] [Related]  

  • 2. miR-133a acts as a tumor suppressor in colorectal cancer by targeting eIF4A1.
    Li W; Chen A; Xiong L; Chen T; Tao F; Lu Y; He Q; Zhao L; Ou R; Xu Y
    Tumour Biol; 2017 May; 39(5):1010428317698389. PubMed ID: 28466778
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Metabolic Maturation during Muscle Stem Cell Differentiation Is Achieved by miR-1/133a-Mediated Inhibition of the Dlk1-Dio3 Mega Gene Cluster.
    Wüst S; Dröse S; Heidler J; Wittig I; Klockner I; Franko A; Bonke E; Günther S; Gärtner U; Boettger T; Braun T
    Cell Metab; 2018 May; 27(5):1026-1039.e6. PubMed ID: 29606596
    [TBL] [Abstract][Full Text] [Related]  

  • 4. The clinical significance and biological function of tropomyosin 4 in colon cancer.
    Yang R; Zheng G; Ren D; Chen C; Zeng C; Lu W; Li H
    Biomed Pharmacother; 2018 May; 101():1-7. PubMed ID: 29455030
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Transgenic overexpression of miR-133a in skeletal muscle.
    Deng Z; Chen JF; Wang DZ
    BMC Musculoskelet Disord; 2011 May; 12():115. PubMed ID: 21615921
    [TBL] [Abstract][Full Text] [Related]  

  • 6. MicroRNA-133a acts as a tumour suppressor in breast cancer through targeting LASP1.
    Sui Y; Zhang X; Yang H; Wei W; Wang M
    Oncol Rep; 2018 Feb; 39(2):473-482. PubMed ID: 29207145
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Temporal analysis of reciprocal miRNA-mRNA expression patterns predicts regulatory networks during differentiation in human skeletal muscle cells.
    Sjögren RJ; Egan B; Katayama M; Zierath JR; Krook A
    Physiol Genomics; 2015 Mar; 47(3):45-57. PubMed ID: 25547110
    [TBL] [Abstract][Full Text] [Related]  

  • 8. MicroRNA-133a inhibits proliferation and invasion, and induces apoptosis in gastric carcinoma cells via targeting fascin actin-bundling protein 1.
    Lai C; Chen Z; Li R
    Mol Med Rep; 2015 Jul; 12(1):1473-8. PubMed ID: 25815687
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Cell Density and Joint microRNA-133a and microRNA-696 Inhibition Enhance Differentiation and Contractile Function of Engineered Human Skeletal Muscle Tissues.
    Cheng CS; Ran L; Bursac N; Kraus WE; Truskey GA
    Tissue Eng Part A; 2016 Apr; 22(7-8):573-83. PubMed ID: 26891613
    [TBL] [Abstract][Full Text] [Related]  

  • 10. miR-133a inhibits cervical cancer growth by targeting EGFR.
    Song X; Shi B; Huang K; Zhang W
    Oncol Rep; 2015 Sep; 34(3):1573-80. PubMed ID: 26134491
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Tumor suppressive microRNA-133a regulates novel targets: moesin contributes to cancer cell proliferation and invasion in head and neck squamous cell carcinoma.
    Kinoshita T; Nohata N; Fuse M; Hanazawa T; Kikkawa N; Fujimura L; Watanabe-Takano H; Yamada Y; Yoshino H; Enokida H; Nakagawa M; Okamoto Y; Seki N
    Biochem Biophys Res Commun; 2012 Feb; 418(2):378-83. PubMed ID: 22266319
    [TBL] [Abstract][Full Text] [Related]  

  • 12. CXCL12/CXCR4 promotes inflammation-driven colorectal cancer progression through activation of RhoA signaling by sponging miR-133a-3p.
    Yu X; Wang D; Wang X; Sun S; Zhang Y; Wang S; Miao R; Xu X; Qu X
    J Exp Clin Cancer Res; 2019 Jan; 38(1):32. PubMed ID: 30678736
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Distinct roles for miR-1 and miR-133a in the proliferation and differentiation of rhabdomyosarcoma cells.
    Rao PK; Missiaglia E; Shields L; Hyde G; Yuan B; Shepherd CJ; Shipley J; Lodish HF
    FASEB J; 2010 Sep; 24(9):3427-37. PubMed ID: 20466878
    [TBL] [Abstract][Full Text] [Related]  

  • 14. miR-145, miR-133a and miR-133b: Tumor-suppressive miRNAs target FSCN1 in esophageal squamous cell carcinoma.
    Kano M; Seki N; Kikkawa N; Fujimura L; Hoshino I; Akutsu Y; Chiyomaru T; Enokida H; Nakagawa M; Matsubara H
    Int J Cancer; 2010 Dec; 127(12):2804-14. PubMed ID: 21351259
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Tumour suppressor properties of miR-15a and its regulatory effects on BCL2 and SOX2 proteins in colorectal carcinomas.
    Gopalan V; Ebrahimi F; Islam F; Vider J; Qallandar OB; Pillai S; Lu CT; Lam AK
    Exp Cell Res; 2018 Sep; 370(2):245-253. PubMed ID: 29958837
    [TBL] [Abstract][Full Text] [Related]  

  • 16. miR-133a represses tumour growth and metastasis in colorectal cancer by targeting LIM and SH3 protein 1 and inhibiting the MAPK pathway.
    Wang H; An H; Wang B; Liao Q; Li W; Jin X; Cui S; Zhang Y; Ding Y; Zhao L
    Eur J Cancer; 2013 Dec; 49(18):3924-35. PubMed ID: 23968734
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Tumor suppressor functions of miR-133a in colorectal cancer.
    Dong Y; Zhao J; Wu CW; Zhang L; Liu X; Kang W; Leung WW; Zhang N; Chan FK; Sung JJ; Ng SS; Yu J
    Mol Cancer Res; 2013 Sep; 11(9):1051-60. PubMed ID: 23723074
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Long non-coding RNA deleted in lymphocytic leukaemia 1 promotes hepatocellular carcinoma progression by sponging miR-133a to regulate IGF-1R expression.
    Zhang W; Liu S; Liu K; Liu Y
    J Cell Mol Med; 2019 Aug; 23(8):5154-5164. PubMed ID: 31207081
    [TBL] [Abstract][Full Text] [Related]  

  • 19. miR-133a-3p Targets SUMO-Specific Protease 1 to Inhibit Cell Proliferation and Cell Cycle Progress in Colorectal Cancer.
    Zhou GQ; Han F; Shi ZL; Yu L; Li XF; Yu C; Shen CL; Wan DW; Zhu XG; Li R; He SB
    Oncol Res; 2018 Jun; 26(5):795-800. PubMed ID: 28748780
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Actin-related protein 2/3 complex subunit 5 (ARPC5) contributes to cell migration and invasion and is directly regulated by tumor-suppressive microRNA-133a in head and neck squamous cell carcinoma.
    Kinoshita T; Nohata N; Watanabe-Takano H; Yoshino H; Hidaka H; Fujimura L; Fuse M; Yamasaki T; Enokida H; Nakagawa M; Hanazawa T; Okamoto Y; Seki N
    Int J Oncol; 2012 Jun; 40(6):1770-8. PubMed ID: 22378351
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 11.